391 related articles for article (PubMed ID: 30917731)
1. Anti-Müllerian hormone levels in recurrent embryonic miscarriage patients are frequently abnormal, and may affect pregnancy outcomes.
McCormack CD; Leemaqz SY; Furness DL; Dekker GA; Roberts CT
J Obstet Gynaecol; 2019 Jul; 39(5):623-627. PubMed ID: 30917731
[TBL] [Abstract][Full Text] [Related]
2. Anti-Mullerian hormone is linked to the type of early pregnancy loss in idiopathic recurrent miscarriage: a retrospective cohort study.
Pils S; Stepien N; Kurz C; Nouri K; Promberger R; Ott J
Reprod Biol Endocrinol; 2017 Aug; 15(1):60. PubMed ID: 28768516
[TBL] [Abstract][Full Text] [Related]
3. Blood anti-Müllerian hormone is a possible determinant of recurrent early miscarriage, yet not conclusive in predicting a further miscarriage.
Leclercq E; de Saint Martin L; Bohec C; Le Martelot MT; Roche S; Alavi Z; Mottier D; Pasquier E
Reprod Biomed Online; 2019 Aug; 39(2):304-311. PubMed ID: 31186176
[TBL] [Abstract][Full Text] [Related]
4. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
[TBL] [Abstract][Full Text] [Related]
5. Diminished ovarian reserve: is it a neglected cause in the assessment of recurrent miscarriage? A cohort study.
Atasever M; Soyman Z; Demirel E; Gencdal S; Kelekci S
Fertil Steril; 2016 May; 105(5):1236-1240. PubMed ID: 26806685
[TBL] [Abstract][Full Text] [Related]
6. Low anti-Müllerian hormone concentration is associated with increased risk of embryonic aneuploidy in women of advanced age.
Jiang X; Yan J; Sheng Y; Sun M; Cui L; Chen ZJ
Reprod Biomed Online; 2018 Aug; 37(2):178-183. PubMed ID: 29724534
[TBL] [Abstract][Full Text] [Related]
7. The role of neopterin and anti-Mullerian hormone in unexplained recurrent pregnancy loss - a case-control study.
Sencan H; Keskin N; Khatib G
J Obstet Gynaecol; 2019 Oct; 39(7):996-999. PubMed ID: 31064238
[TBL] [Abstract][Full Text] [Related]
8. IVF outcomes of women with discrepancies between age and serum anti-Müllerian hormone levels.
Zhang B; Meng Y; Jiang X; Liu C; Zhang H; Cui L; Chen ZJ
Reprod Biol Endocrinol; 2019 Jul; 17(1):58. PubMed ID: 31311571
[TBL] [Abstract][Full Text] [Related]
9. Does preoperative antimüllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis?
Stochino-Loi E; Darwish B; Mircea O; Touleimat S; Millochau JC; Abo C; Angioni S; Roman H
Fertil Steril; 2017 Mar; 107(3):707-713.e3. PubMed ID: 28089574
[TBL] [Abstract][Full Text] [Related]
10. Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome.
Keane K; Cruzat VF; Wagle S; Chaudhary N; Newsholme P; Yovich J
Reprod Biol; 2017 Mar; 17(1):51-59. PubMed ID: 28132758
[TBL] [Abstract][Full Text] [Related]
11. Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity.
Magri F; Schena L; Capelli V; Gaiti M; Zerbini F; Brambilla E; Rotondi M; De Amici M; Spinillo A; Nappi RE; Chiovato L
Reprod Biol Endocrinol; 2015 Sep; 13(1):106. PubMed ID: 26391773
[TBL] [Abstract][Full Text] [Related]
12. Antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) are the predictors of natural fecundability have similar trends irrespective of fertility status and menstrual characteristics among fertile and infertile women below the age of 40 years.
Khan HL; Bhatti S; Suhail S; Gul R; Awais A; Hamayun H; Enver F; Abbas S; Hassan Z; Nisar R; Sardar S; Asif W
Reprod Biol Endocrinol; 2019 Feb; 17(1):20. PubMed ID: 30744650
[TBL] [Abstract][Full Text] [Related]
13. Does the anti-Müllerian hormone truly reflect ovarian response in women with endometrioma?
Inal ZO; Engin Ustun Y; Yilmaz N; Aktulay A; Bardakci Y; Gulerman C
J Obstet Gynaecol; 2019 May; 39(4):516-521. PubMed ID: 30744464
[TBL] [Abstract][Full Text] [Related]
14. The role of ovarian reserve markers in prediction of clinical pregnancy.
Zebitay AG; Cetin O; Verit FF; Keskin S; Sakar MN; Karahuseyinoglu S; Ilhan G; Sahmay S
J Obstet Gynaecol; 2017 May; 37(4):492-497. PubMed ID: 28421902
[TBL] [Abstract][Full Text] [Related]
15. Correlation of age and antimullerian hormone in assisted reproductive technology program outcome.
Himabindu Y; Gopinathan KK; Pandey AK; Sriharibabu M
Indian J Physiol Pharmacol; 2013; 57(1):9-15. PubMed ID: 24020093
[TBL] [Abstract][Full Text] [Related]
16. Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene.
Schufreider A; McQueen DB; Lee SM; Allon R; Uhler ML; Davie J; Feinberg EC
Hum Reprod; 2015 Nov; 30(11):2686-92. PubMed ID: 26345686
[TBL] [Abstract][Full Text] [Related]
17. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
Li Y; Tan JQ; Mai ZY; Yang DZ
Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
[No Abstract] [Full Text] [Related]
18. Is diminished ovarian reserve a risk factor for miscarriage? Results of a systematic review and meta-analysis.
Busnelli A; Somigliana E; Cirillo F; Levi-Setti PE
Hum Reprod Update; 2021 Oct; 27(6):973-988. PubMed ID: 34254138
[TBL] [Abstract][Full Text] [Related]
19. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF.
Fabregues F; González-Foruria I; Peñarrubia J; Carmona F
Hum Reprod; 2018 Sep; 33(9):1696-1704. PubMed ID: 30016431
[TBL] [Abstract][Full Text] [Related]
20. Diminished ovarian reserve in recurrent pregnancy loss: a systematic review and meta-analysis.
Bunnewell SJ; Honess ER; Karia AM; Keay SD; Al Wattar BH; Quenby S
Fertil Steril; 2020 Apr; 113(4):818-827.e3. PubMed ID: 32145928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
